Leaps by Bayer
Corporate VCSeed–Growth
What they invest in
from 6 of 6 portfolio companiesBiotech ×5AI & Machine Learning ×2Deep Tech ×2Digital Health ×2FoodTech ×2Medical Devices ×2Healthtech ×1HR Tech ×1
HQs:United States×2
Investments · 6 tracked
founders shown can be your intro pathSoufflé Therapeutics develops nucleic acid medicines that precisely target and deliver genetic therapeutics to specific cell types to treat disease. The company focuses on creating potent, precise medicines for patients across various disease areas through advanced delivery platforms.
AI & Machine LearningBiotechDeep Tech
Victor Kotelianski(Founder)Daniel Anderson(Founder)Robert Langer(Founder)Marino Zerial(Founder)
Fork & Good develops cultivated meat technology using a hydroponic system approach that integrates cell biology with farming principles to produce real meat from cells at scale. The company serves food manufacturers and works toward making cultivated meat commercially viable and sustainable.
BiotechDeep TechFoodTech
Gabor Forgacs(Chief Scientific Officer and co-founder)Andras Forgacs(Partner and co-founder)Niya Sharma(Co-founder)
Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies. The company is building on research from academic institutions including Dana Farber Cancer Institute and MIT.
BiotechDigital HealthMedical Devices
Nava provides employee benefits advisory and administration services combining expert consultants with AI-powered tools to reduce administrative burden for HR teams and deliver healthcare cost savings for employers. The platform serves as a modern alternative to traditional brokers, handling benefits management, employee communications, and strategy optimization.
AI & Machine LearningHR TechSaaS
NextPoint is developing precision cancer therapeutics based on the B7-H7/HHLA2 axis, including T-cell engagers, antibody-drug conjugates, and checkpoint inhibitors for cancer patients. The company focuses on immuno-oncology and tumor-targeting therapies.
BiotechDigital HealthMedical DevicesAustin, US
One.bio develops food products designed to provide beneficial molecular signals to support health and address chronic inflammatory disease. The company applies rigorous molecular science to food composition and production.
BiotechFoodTechHealthtechWellness & Fitness
Matt Amicucci(Co-Founder & Chief Science Officer)Matt Barnard(Co-Founder & CEO)
Frequently asked questions
- What stage does Leaps by Bayer invest at?
- Leaps by Bayer invests at the Seed, Series A, Series B, Series C, Growth stages.
Similar investors
500 Global's Sustainable Growth practice designs and implements sovereign-aligned strategies that unlock resilient, inclusive, and sustainable economic growth across the Global Majority—Asia, Africa, Latin America, and the Middle East. The practice bridges public priorities and private capital through ecosystem development, blended finance, and localized innovation programs addressing health, agriculture, gender, climate, and education.
a16z is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz that invests in seed through growth-stage technology companies across multiple sectors including AI, healthcare, consumer, crypto, enterprise, fintech, and gaming. The firm manages over $100 billion in assets and operates a distinctive platform model with a large team of operators supporting founders throughout their journey.
August Capital is a venture capital firm headquartered in the San Francisco Bay Area that has invested in early-stage startups across information technology since 1995. The firm manages approximately $2 billion in assets and combines capital deployment with operational support and networking assistance to help entrepreneurs build successful companies.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Balderton is a European venture capital firm that has invested in over 300 companies across all stages from seed through IPO since 2000. With €5.7 billion raised to invest, the firm provides substantial capital and hands-on operational support through its experienced partnership team and portfolio services.